Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...
Read Full NewsThe rheumatology year in review highlights FDA approvals and pivotal data readouts.
Johnson & Johnson plans to initiate a phase 3 study based off the positive data.
Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.
Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.
The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.
Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101
Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression
1.
Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma
2.
Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.
3.
Alone for 500 Days, but Never Lonely: The Introvert's Dream.
4.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
5.
Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors
1.
The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective
2.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
3.
Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics
4.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
5.
The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge